Skip to main content
Equibles

ALLIANCEBERNSTEIN L.P.

Position in ZYME — Zymeworks Inc.

CIK 1109448 NASHVILLE, TN
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,461,121
+$61,486 QoQ
Shares Held
55,896
0.0% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 202 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 93% Shared 0% None 7%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ALLIANCEBERNSTEIN L.P. holds $5,185,395,108 across 257 Biotechnology names. ZYME ranks #115 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,019,315 $1,499,784,339
2 ARGX
Argenx SE
 395,661 $367,082,405
3 GMAB
Genmab A/S
 8,644,877 $237,474,771
4 REGN
Regeneron Pharmaceuticals, Inc.
 292,338 $182,284,436
5 TECH
BIO-TECHNE Corp
 2,002,026 $141,443,136
6 HALO
Halozyme Therapeutics, Inc.
 1,696,538 $132,788,029
7 KYMR
Kymera Therapeutics, Inc.
 981,521 $112,551,013
8 BBIO
BridgeBio Pharma, Inc.
 1,453,504 $108,256,977

All Filings in ZYME

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,461,121 55,896
2026-03-31 $1,399,635 55,896
2025-12-31 $1,317,289 50,030
2025-09-30 $854,512 50,030
2025-06-30 $627,876 50,030
2025-03-31 $595,857 50,030
2024-12-31 $732,439 50,030
2024-09-30 $627,876 50,030
2024-06-30 $425,755 50,030
2024-03-31 $528,630 50,250
2023-12-31 $371,858 35,790
2023-09-30 $200,851 31,680
2023-06-30 $148,780 17,220